Univasc
Product Images NDC 0091-3707

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Univasc (NDC 0091-3707). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ucb, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Univasc 01)

FDA Label Image

7.5 mg Tablets Bottle Label (Univasc 02)

7.5 mg Tablets Bottle Label (Univasc 02)
This is a description of the medicine Univasc, which contains moexipril HCI. It comes in tablet form and each scored tablet contains 7.5mg of moexipril hydrochloride. It is only available with a prescription and must be stored at controlled room temperature in a tight container to protect it from moisture. The package insert should be consulted for full prescribing information and usual dosage. The manufacturer is listed as UGB Inc, located in Smyrna, GA. The control number and expiration date are not provided.*
FDA Label Image

15 mg Tablets Bottle Label (Univasc 03)

15 mg Tablets Bottle Label (Univasc 03)
The text provides information about the drug Univasc, specifically the tablets form of the drug. The drug's NDC is 0091-3715-01, and the tablets contain 15mg of Moexipril hydrochloride. The drug is only available with a prescription and should be stored at controlled room temperature away from excessive moisture. The text advises to dispense the drug in tight containers per the USP-NF standard. For dosage information, refer to the package insert. The manufacturer is UGB Inc, located in Smyrna, GA.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.